Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06482970

Effectiveness of Exercise Plus Pain Neuroscience Education on Brain Function in Knee Osteoarthritis

Brain Function, Clinical and Psychosocial Outcomes After Neuromuscular Exercise Plus Pain Neuroscience Education Intervention in Patients With Chronic Pain Due to Knee Osteoarthritis. A Randomized Controlled Trial Protocol

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
57 (estimated)
Sponsor
Universidad Santo Tomas, Chile · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

A three-arm randomized controlled trial will be conducted. Fifty-nine participants with KOA will be recruited in a 1:1:1 ratio. Assessor, and statistician will be blinded to group allocation. One experimental group (n=19) will receive NME plus PNE, the other experimental group (n=19) will receive isolated NME and the control group (n=19) will continue with usual care. The PNE will be adapted to the context of the participants. Outcome measures will be brain activity, pressure pain threshold, pain intensity, disability, fear-avoidance beliefs, self-efficacy, and pain catastrophizing. Outcome measures will be evaluated pre-intervention, immediately post-intervention, and four-month post-intervention. The investigators hypothesize that there will be significant differences in favor of the NME plus PNE intervention group.

Conditions

Interventions

TypeNameDescription
OTHERNeuromuscular exercise plus pain neuroscience educationThe exercises follow neuromuscular principles, which aim to improve sensorimotor control and achieve compensatory functional stability (also called dynamic stability). Pain neuroscience education will take an active, person-centered approach through their own fear-avoidance beliefs.
OTHERNeuromuscular exerciseThe exercises follow neuromuscular principles, which aim to improve sensorimotor control and achieve compensatory functional stability (also called dynamic stability).

Timeline

Start date
2025-03-15
Primary completion
2025-11-30
Completion
2025-12-30
First posted
2024-07-01
Last updated
2024-07-01

Source: ClinicalTrials.gov record NCT06482970. Inclusion in this directory is not an endorsement.